MannKind Corp (MNKD)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $1.27B
Last updated: Nov 17, 2026 at 4:40 PM ET
MannKind Corp (MNKD) Stock Chart
MannKind (MNKD) has a latest price of $4.07 on Nov 17, 2026, 37.5% below its 52-week high of $6.51. Its price fell 19.6% over the past 12 months. The month-end price rose 67.8% over the 10 years through Oct 2026, a compound annual rate of 5.3%.
Price Chart
From Oct 2016 to Oct 2026, its highest month-end close was $7.07 in Oct 2024 and its lowest $0.87 in Apr 2017, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart MNKD with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for MNKD.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price fell 7.4%, and over 6 months it rose 37.5%. The month-end price fell 18.4% over the 3 years through Oct 2026, a compound annual decline of 6.6%.
| Period | Change |
|---|---|
| 1 month | +31.7% |
| 3 months | -7.4% |
| 6 months | +37.5% |
| 12 months | -19.6% |
| 12 months, with dividends | -19.6% |
| Period | Change | Per year |
|---|---|---|
| 3 years | -18.4% | -6.6% |
| 5 years | -25.7% | -5.8% |
| 10 years | +67.8% | +5.3% |
Price by Year
Its best calendar year was 2020, when the price rose 142.6%, and its weakest was 2018, when it fell 54.3%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $3.50 | -38.3% |
| 2025 | $5.67 | -11.8% |
| 2024 | $6.43 | +76.6% |
| 2023 | $3.64 | -30.9% |
| 2022 | $5.27 | +20.6% |
| 2021 | $4.37 | +39.6% |
| 2020 | $3.13 | +142.6% |
| 2019 | $1.29 | +21.7% |
| 2018 | $1.06 | -54.3% |
| 2017 | $2.32 | -27.1% |
Trading Range
The price is 14.1% above its 50-day average of $3.57 and 12.1% above its 200-day average of $3.63.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $4.07 | |
| 52-week high | $6.51 | -37.5% |
| 52-week low | $2.23 | +82.5% |
| 50-day average | $3.57 | +14.1% |
| 200-day average | $3.63 | +12.1% |
Price Risk
Over 3 years, its largest fall from a peak was 69.4%.
| Measure | Value |
|---|---|
| 1-year beta | 0.99 |
| Largest fall, 1 year | -63.3% |
| Largest fall, 3 years | -69.4% |
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About MNKD
What is MNKD's 1-year price change?
MannKind's price fell 19.6% over the past 12 months. With dividends included, the 12-month total return was -19.6%.
What is MNKD's 5-year price change?
MannKind's month-end price fell 25.7% over the 5 years through Oct 2026, a compound annual decline of 5.8%. These figures leave out dividends.
What is MNKD's 52-week high and low?
MannKind's 52-week high is $6.51 and its 52-week low is $2.23. Its latest price of $4.07 on Nov 17, 2026 is 37.5% below the high.
What is MNKD's beta?
MannKind's 1-year beta against the S&P 500 is 0.99, so its price has moved about in line with the market over the past year. Its largest fall from a peak over the past year was 63.3%.
Is the MNKD chart free?
Yes. Advanced Charting for MNKD is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
MNKD pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Competitors